Pricing Log in Create free account

NeuroSense Therapeutics Ltd. (NRSN) vs Xenetic Biosciences, Inc. (XBIO)

NeuroSense Therapeutics Ltd. and Xenetic Biosciences, Inc. are both Biotechnology companies. NeuroSense Therapeutics Ltd. and Xenetic Biosciences, Inc. are of similar size ($4.6M and $4.5M). NeuroSense Therapeutics Ltd. has the higher net margin (0.00% vs −75.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, NeuroSense Therapeutics Ltd. leads on 6 and Xenetic Biosciences, Inc. on 4.

Valuation

Metric NRSN XBIO Biotechnology median
P/E n/m n/m 8.58
P/S n/m 1.34 10.29
P/B n/m 0.72 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m 0.37 0.67
EV/Sales n/m (0.30) 9.89
Earnings yield (520.49%) (61.05%) (31.56%)
Free cash flow yield (568.39%) (53.01%) (23.42%)

Profitability

Metric NRSN XBIO Biotechnology median
Gross margin — 100.00% 65.77%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity 0.00% (47.05%) (54.09%)
Return on assets 0.00% (40.17%) (47.78%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRSN XBIO Biotechnology median
Revenue growth (TTM) — 33.30% 5.83%
EPS growth (last fiscal year) 18.52% 38.52% 29.36%
Revenue growth, 5-year CAGR — 46.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRSN XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.28 7.43 4.80
Net debt to EBITDA 0.01 2.78 0.97

Dividend

Metric NRSN XBIO Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric NRSN XBIO Biotechnology median
Market cap 4.63m 4.52m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack